Soligenix, Inc. (SNGX)

1.09 +0.03 (+2.83%) USD  |  NASDAQ  |  Feb 13, 16:00
1.10 +0.01 (+0.92%) After-Hours: 20:00
More

Soligenix EPS Diluted (Quarterly) : -0.5846 for Sept. 30, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for SNGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Amgen, Inc. 2.455
Amicus Therapeutics, Inc. 0.0558
Insmed, Inc. -1.747
Merck & Co., Inc. 1.191
Tonix Pharmaceuticals Holding Corp. -3.587

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -2.531M
Total Expenses (Quarterly) 2.531M
Enterprise Value 0.8536M
Earnings Yield -335.6%
Normalized Earnings Yield -341.90